|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.55 USD | -0.39% |
|
-2.68% | +26.74% |
| 13/07 | Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth… |  |
| 07/07 | RBC Capital Adjusts Exelixis Price Target to $46 From $43, Maintains Sector Perform Rating | MT |
MarketScreener Strategies
Search
 | Exelixis, Inc. : The cure to cancer? | August 05, 2025 at 07:19 pm IST |
 | Exelixis Q1 25 results boost stock and target price | June 25, 2025 at 01:31 pm IST |
No results match your criteria
- Stock Market
- Stocks
- EXEL Stock
- News Exelixis, Inc.
- MarketScreener Strategies
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition